Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects (FTIH)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01494636
First received: November 17, 2011
Last updated: November 21, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)